Indian Pharma industry moving towards formulations

Indian Pharma industry is slowing moving up the value chain. Earlier it used to manufacture active pharmaceutical ingredient at low cost compared to world. Now with competition from China, which provides API at 15-20% low cost, it makes sense to shift focus elsewhere. Many top companies like Lupin, Novartis, Ranbaxy have less revenue stream from API than from formulations. There could also be the reason that formulation business has grown faster than APIs for some companies. API is low scale commodity with low margin. Moreover, with a large number of patent expiries in developed markets like the US and Europe, Indian companies, with skills to develop and manufacture low-cost generic drugs, see a much more lucrative opportunity there than utilising their capacities for manufacturing APIs.
Read More

  • No Image
    Kilburn Chemicals Ltd

    Kilburn Chemicals Limited (KCL) is a leading producer and exporter of Anatase Grade Titanium Dioxide in India. It produces Titanium Dioxide by the Sulphate route. KCL also manuf

  • No Image
    KJD Pharma Pvt Ltd

    KJD Pharma Pvt Ltd was incorporated in Bidar on 25th March 2014. The company intends to manufacture generic tablets used as Anti-inflammatory, Anti Allergic, Anti Infertility, A

  • No Image
    Kopran Ltd

    Kopran is the group company of Parijat Enterprises. Kopran is currently an integrated Pharmaceutical Company manufacturing a large range of products. It manufactures both Active

  • No Image
    Kosher Pharmaceuticals Ltd

    Kosher Pharmaceuticals Ltd is engaged in production of formulations and has manufacturing facilities that meets international standards like USFDA , cGMP and WHO Standards. They